{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:15:23Z","timestamp":1774610123989,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"DOI":"10.7759\/cureus.63385","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T17:00:53Z","timestamp":1719594053000},"source":"Crossref","is-referenced-by-count":4,"title":["Gemcitabine-Induced Thrombotic Microangiopathy in a Patient With Cholangiocarcinoma: An Atypical Case"],"prefix":"10.7759","author":[{"given":"Vishwanath","family":"Anil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ensaf","family":"Alhujaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeksha","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolina P","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok Kumar","family":"Kanugula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moyosore","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: a systematic review","volume":"21","author":"Izzedine H","year":"2006","unstructured":"Izzedine H, Isnard-Bagnis C, Launay-Vacher V, et al.. Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant. 2006, 21:3038-45. 10.1093\/ndt\/gfl507","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28433","article-title":"Gemcitabine-induced thrombotic microangiopathy managed conservatively in a patient of breast cancer","volume":"14","author":"Ghumman GM","year":"2022","unstructured":"Ghumman GM, Fatima H, Johnston TL, Leis R, Khatri V. Gemcitabine-induced thrombotic microangiopathy managed conservatively in a patient of breast cancer. Cureus. 2022, 14:e28433. 10.7759\/cureus.28433","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-22-509","article-title":"Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report","volume":"13","author":"Van den Eeckhaut L","year":"2022","unstructured":"Van den Eeckhaut L, Hannon H, Schurgers M, Monsaert E, Claes K. Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report. J Gastrointest Oncol. 2022, 13:3314-20. 10.21037\/jgo-22-509","journal-title":"J Gastrointest Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20290","article-title":"Gemcitabine-associated thrombotic microangiopathy","volume":"100","author":"Humphreys BD","year":"2004","unstructured":"Humphreys BD, Sharman JP, Henderson JM, et al.. Gemcitabine-associated thrombotic microangiopathy. Cancer. 2004, 100:2664-70. 10.1002\/cncr.20290","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000000000061","article-title":"Chemotherapy-associated thrombotic microangiopathy","volume":"4","author":"Aklilu AM","year":"2023","unstructured":"Aklilu AM, Shirali AC. Chemotherapy-associated thrombotic microangiopathy. Kidney360. 2023, 4:409-22. 10.34067\/KID.0000000000000061","journal-title":"Kidney360"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1088031","article-title":"Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli T","year":"2022","unstructured":"Mazzierli T, Allegretta F, Maffini E, Allinovi M. Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management. Front Pharmacol. 2022, 13:1088031. 10.3389\/fphar.2022.1088031","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000520484","article-title":"Thrombotic microangiopathy associated with gemcitabine in non-small cell lung cancer: a case report","volume":"14","author":"Kuribayashi T","year":"2021","unstructured":"Kuribayashi T, Fujiwara K, Onishi K, et al.. Thrombotic microangiopathy associated with gemcitabine in non-small cell lung cancer: a case report. Case Rep Oncol. 2021, 14:1712-8. 10.1159\/000520484","journal-title":"Case Rep Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3088","article-title":"Drug-induced thrombotic microangiopathy caused by gemcitabine","volume":"10","author":"Hasan A","year":"2018","unstructured":"Hasan A, Jain AG, Naim H, Munaf A, Everett G. Drug-induced thrombotic microangiopathy caused by gemcitabine. Cureus. 2018, 10:e3088. 10.7759\/cureus.3088","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5576","article-title":"Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: a case report","volume":"13","author":"Lai-Tiong F","year":"2017","unstructured":"Lai-Tiong F, Duval Y, Krabansky F. Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: a case report. Oncol Lett. 2017, 13:1201-3. 10.3892\/ol.2017.5576","journal-title":"Oncol Lett"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2016.649","article-title":"Cancer-associated thrombotic microangiopathy","volume":"10","author":"Govind Babu K","year":"2016","unstructured":"Govind Babu K, Bhat GR. Cancer-associated thrombotic microangiopathy. Ecancermedicalscience. 2016, 10:649. 10.3332\/ecancer.2016.649","journal-title":"Ecancermedicalscience"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13808","article-title":"Thrombotic microangiopathy associated with gemcitabine use: presentation and outcome in a national French retrospective cohort","volume":"85","author":"Daviet F","year":"2019","unstructured":"Daviet F, Rouby F, Poullin P, et al.. Thrombotic microangiopathy associated with gemcitabine use: presentation and outcome in a national French retrospective cohort. Br J Clin Pharmacol. 2019, 85:403-12. 10.1111\/bcp.13808","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.ijn_321_22","article-title":"Gemcitabine-induced renal thrombotic microangiopathy","volume":"33","author":"Chaudhary A","year":"2023","unstructured":"Chaudhary A, Sethi J, Garg S, Sekar A, Kohli HS. Gemcitabine-induced renal thrombotic microangiopathy. Indian J Nephrol. 2023, 33:319-20. 10.4103\/ijn.ijn_321_22","journal-title":"Indian J Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260152-gemcitabine-induced-thrombotic-microangiopathy-in-a-patient-with-cholangiocarcinoma-an-atypical-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T17:01:08Z","timestamp":1719594068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260152-gemcitabine-induced-thrombotic-microangiopathy-in-a-patient-with-cholangiocarcinoma-an-atypical-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.63385","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}